Gut microbial biomarkers for major depressive disorder: a cross-sectional study

Area of Science:

• Microbiome research
• Psychiatric disorders
• Metagenomics

Background:

• Gut microbiota alterations are linked to psychiatric disorders like major depressive disorder (MDD).
• Previous research on MDD and gut microbes has mainly focused on bacteria, neglecting other microbial components.
• The precise relationship between MDD and gut microbial communities requires further elucidation.

Purpose of the Study:

• To investigate the potential of gut bacterial and viral biomarkers for major depressive disorder (MDD) assessment.
• To evaluate the predictive performance of microbial biomarkers in MDD.
• To explore the utility of integrating multi-domain microbial features for improved MDD prediction.

Main Methods:

• Analyzed gut microbial profiles from 36 MDD patients and 36 healthy controls using metagenomic sequencing.
• Employed the MaAsLin2 algorithm to identify microbial biomarkers associated with MDD.
• Validated findings through external testing in two independent research cohorts (Shanxi and Wuhan).

Main Results:

• Identified 6 bacterial and 7 viral biomarkers associated with MDD.
• Achieved high predictive performance with Area Under the Curve (AUC) values of 0.891 for bacteria and 0.878 for viruses.
• A combined bacterial-viral model demonstrated superior predictive power, with AUCs of 0.946 in the primary cohort, 0.972 in the Shanxi cohort, and 0.784 in the Wuhan cohort.

Conclusions:

• Gut bacterial and viral biomarkers show promise as auxiliary tools for MDD assessment.
• Integrating multi-domain microbial data can enhance the accuracy of MDD prediction.
• Further research into microbial signatures may offer novel avenues for understanding and managing MDD.